We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 41-60 of 6,232 results
  1. DR6 Augments Colorectal Cancer Cell Growth, Invasion, and Stemness by Activating AKT/NF-κB Pathway

    This study aims to elucidate the role and mechanisms of Death Receptor 6 (DR6), a member of the tumor necrosis factor receptor superfamily, in the...

    **g Jia, Yisen Huang, ... Chunkang Yang in Biochemical Genetics
    Article Open access 13 March 2024
  2. The role of LOXL2 induced by glucose metabolism-activated NF-κB in maintaining drug resistance through EMT and cancer stemness in gemcitabine-resistant PDAC

    Abstract

    Gemcitabine is considered a standard treatment for pancreatic cancer, but develo** drug resistance greatly limits the effectiveness of...

    Yun Sun Lee, Hyung Sun Kim, ... Joon Seong Park in Journal of Molecular Medicine
    Article Open access 22 September 2023
  3. TC2N inhibits distant metastasis and stemness of breast cancer via blocking fatty acid synthesis

    Background

    Tandem C2 domains, nuclear (TC2N) is a C2 domain-containing protein that belongs to the carboxyl-terminal type (C-type) tandem C2 protein...

    **ang-lin Hao, Yang-fan Lv, ... Qiao-nan Guo in Journal of Translational Medicine
    Article Open access 02 January 2024
  4. Exposure of piperlongumine attenuates stemness and epithelial to mesenchymal transition phenotype with more potent anti-metastatic activity in SOX9 deficient human lung cancer cells

    Phytocompounds have shown hopeful results in cancer therapy. Piperlongumine (PIP), a naturally derived bioactive alkaloid found in our dietary spice,...

    Surya Kant Tripathi, Rajeev Kumar Sahoo, Bijesh Kumar Biswal in Naunyn-Schmiedeberg's Archives of Pharmacology
    Article 27 January 2024
  5. USP51 promotes non-small cell lung carcinoma cell stemness by deubiquitinating TWIST1

    Background

    USP51 is a deubiquitinase (DUB), that is involved in diverse cellular processes. Accumulating evidence has demonstrated that USP51...

    ** Chen, Zhongqiu Wu, ... Wenting Li in Journal of Translational Medicine
    Article Open access 08 July 2023
  6. Identification of stemness-related glycosylation changes in head and neck squamous cell carcinoma

    Background

    Altered glycosylation is a hallmark of cancer associated with therapy resistance and tumor behavior. In this study, we investigated the...

    E Routila, R Mahran, ... J Leivo in BMC Cancer
    Article Open access 10 April 2024
  7. Transition of amyloid/mutant p53 from tumor suppressor to an oncogene and therapeutic approaches to ameliorate metastasis and cancer stemness

    The tumor suppressor p53 when undergoes amyloid formation confers several gain-of-function (GOF) activities that affect molecular pathways crucial...

    Shin**ee Sengupta, Shaikh Maryam Ghufran, ... Susanta Roychoudhury in Cancer Cell International
    Article Open access 26 December 2022
  8. HERC2 promotes inflammation-driven cancer stemness and immune evasion in hepatocellular carcinoma by activating STAT3 pathway

    Background

    Hepatic inflammation is a common initiator of liver diseases and considered as the primary driver of hepatocellular carcinoma (HCC)....

    Yunzhi Liu, Qishan Xu, ... Daming Zuo in Journal of Experimental & Clinical Cancer Research
    Article Open access 01 February 2023
  9. Treatment with decitabine induces the expression of stemness markers, PD-L1 and NY-ESO-1 in colorectal cancer: potential for combined chemoimmunotherapy

    Background

    The mechanism of tumor immune escape and progression in colorectal cancer (CRC) is widely investigated in-vitro to help understand and...

    Nassiba Taib, Maysaloun Merhi, ... Said Dermime in Journal of Translational Medicine
    Article Open access 31 March 2023
  10. Protein homeostasis maintained by HOOK1 levels promotes the tumorigenic and stemness properties of ovarian cancer cells through reticulum stress and autophagy

    Background

    Ovarian cancer has a high mortality rate mainly due to its resistance to currently used therapies. This resistance has been associated with...

    Elisa Suárez-Martínez, Sander R. Piersma, ... Amancio Carnero in Journal of Experimental & Clinical Cancer Research
    Article Open access 29 May 2024
  11. Type I IFNs promote cancer cell stemness by triggering the epigenetic regulator KDM1B

    Cancer stem cells (CSCs) are a subpopulation of cancer cells endowed with high tumorigenic, chemoresistant and metastatic potential. Nongenetic...

    Martina Musella, Andrea Guarracino, ... Antonella Sistigu in Nature Immunology
    Article Open access 24 August 2022
  12. Therapeutics of Oxidative Stress and Stemness in Breast Cancer

    Oxidative stress (OS) is induced by chemical reactions triggered inside our body by generation of reactive oxygen and nitrogen species and externally...
    Balraj Singh, Kalpana Mujoo, Anthony Lucci in Handbook of Oxidative Stress in Cancer: Mechanistic Aspects
    Reference work entry 2022
  13. Essential role of PLD2 in hypoxia-induced stemness and therapy resistance in ovarian tumors

    Background

    Hypoxia in solid tumors is an important source of chemoresistance that can determine poor patient prognosis. Such chemoresistance relies on...

    Sandra Muñoz-Galván, Eva M. Verdugo-Sivianes, ... Amancio Carnero in Journal of Experimental & Clinical Cancer Research
    Article Open access 26 February 2024
  14. m6A modified BACE1-AS contributes to liver metastasis and stemness-like properties in colorectal cancer through TUFT1 dependent activation of Wnt signaling

    Background

    Liver metastasis is one of the most important reasons for high mortality of colorectal cancer (CRC). Growing evidence illustrates that...

    **di Wang, Yu Liu, ... Zizhen Si in Journal of Experimental & Clinical Cancer Research
    Article Open access 21 November 2023
  15. Metformin abrogates Fusobacterium nucleatum-induced chemoresistance in colorectal cancer by inhibiting miR-361-5p/sonic hedgehog signaling-regulated stemness

    Background

    Chemotherapy resistance is the major cause of recurrence in patients with colorectal cancer (CRC). A previous study found that Fusobacterium...

    **a-Lu Hong, Ta-Chung Yu, ... Hua **ong in British Journal of Cancer
    Article Open access 17 November 2022
  16. BEX1 supports the stemness of hepatoblastoma by facilitating Warburg effect in a PPARγ/PDK1 dependent manner

    Background

    Hepatoblastoma (HB) is a highly aggressive paediatric malignancy that exhibits a high presence of cancer stem cells (CSCs), which related...

    Qian Wang, Ning Liang, ... Gang Wang in British Journal of Cancer
    Article 15 September 2023
  17. Integrated analysis of single-cell and bulk RNA sequencing data reveals a pan-cancer stemness signature predicting immunotherapy response

    Background

    Although immune checkpoint inhibitor (ICI) is regarded as a breakthrough in cancer therapy, only a limited fraction of patients benefit...

    Zhen Zhang, Zi-**an Wang, ... Rui-Hua Xu in Genome Medicine
    Article Open access 29 April 2022
  18. Identification of prognostic stemness-related genes in kidney renal papillary cell carcinoma

    Background

    Kidney renal papillary cell carcinoma (KIRP) is the second most prevalent malignant cancer originating from the renal epithelium. Nowadays,...

    Yifan Liu, Yuntao Yao, ... **ngang Cui in BMC Medical Genomics
    Article Open access 03 May 2024
  19. RACGAP1 promotes the progression and poor prognosis of lung adenocarcinoma through its effects on the cell cycle and tumor stemness

    Objection

    Investigating the key genes and mechanisms that influence stemness in lung adenocarcinoma.

    Methods

    First, consistent clustering analysis was...

    Yafeng Liu, Tao Han, ... Dong Hu in BMC Cancer
    Article Open access 02 January 2024
  20. FZD7 accelerates hepatic metastases in pancreatic cancer by strengthening EMT and stemness associated with TGF-β/SMAD3 signaling

    Background

    Metastasis of malignant tumors accelerates systemic failure and hastens the deaths of pancreatic cancer patients. During the metastatic...

    Zhongbo Zhang, Yuanhong Xu in Molecular Medicine
    Article Open access 19 July 2022
Did you find what you were looking for? Share feedback.